Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis

American Journal of Pathology

Volumn 149, Issue 5, 1996, Pages 1553-1564

  Loda, Massimo ^a   Capodieci, Paola ^a   Mishra, Rajesh ^a   Yao, Hong ^e   Corless, Christopher ^b,e   Grigioni, Walter ^d   Wang, Youbin ^c   Magi Galluzzi, Cristina ^a   Stork, Philip J S ^e  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATASE; TUMOR MARKER;

ARTICLE; CANCER; CANCER STAGING; CARCINOGENESIS; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARCINOMA; CELL CYCLE PROTEINS; EPITHELIUM; HUMANS; IMMEDIATE-EARLY PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN-TYROSINE KINASES; PROTEIN-TYROSINE-PHOSPHATASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0029904681     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Bishop JM: The molecular genetics of cancer. Science 1987, 235:305-311
2. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisninger AC, Leppert M, Nakamura Y, White R, Smits AMM, Bos JL: Genetic alterations during colorectal tumor development. N Engl J Med 1988, 319:525-532
3. Klein R, Jing S, Nanduri V. O'Rourke E, Barbacid M: The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 1991, 65:189-197
4. Crews CM, Erikson RL: Extracellular signals and reversible protein phosphorylation: what to Mek of it all. Cell 1993, 74:215-217
5. Muthuswamy SK, Siegel PM, Dankort DL, Webster MA, Muller WJ: Mammary tumors expressing the neu protooncogene possess elevated c-src tyrosine kinase activity. Mol Cell Biol 1994, 14:735-743
6. Zheng CF, Guan KL: Cloning and characterization of two distinct human extracellular signal-regulated kinase activator kinases, MEK1 and MEK2. J Biol Chem 1993, 268:11435-11439
7. mapk are required for fibroblast proliferation. Proc Natl Acad Sci USA 1993, 90:8319-8323
8. Lange-Carter CA, Pleiman CM, Gardner AM, Blumer KJ, Johnson GL: A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science 1993, 260:315-319
9. Ruderman JV: MAP kinase and the activation of quiescent cells. Curr Opin Cell Biol 1993, 5:207-213
10. Alessi DR, Smith R, Keyse SM: The human CL100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts. Oncogene 1993, 8:2015-2020
11. Guan K, Broyles SS, Dixon JE: A Tyr/Ser protein phosphatase encoded by vaccinia virus. Nature 1991, 350: 359-362
12. Guan KL, Hakes DJ, Wang Y, Park HD, Cooper TG, Dixon JE: A yeast protein phosphatase related to the vaccinia virus VH1 phosphatase is induced by nitrogen starvation. Proc Natl Acad Sci USA 1992, 89:12175-12179
13. Keyse SM, Emslie EA: Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature 1992, 359:644-647
14. Rohan PJ, Davis P, Moskaluk A, Kearns M, Krutzsch H, Siebenlist U, Kelly K: PAC-1, a mitogen-induced nuclear protein tyrosine phosphatase. Science 1993, 259: 1763-1766
15. Kwak SP, Hakes DJ, Martell KJ, Dixon JE: Isolation and characterization of a human dual specificity protein-tyrosine phosphatase gene. J Biol Chem 1994, 5:3596-1604
16. Sun H, Charles CH, Lau LF, Tonks NK: MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 1993, 75:487-493
17. Kumagai A, Dunphy WG: Regulation of the cdc25 protein during the cell cycle in Xenopus extracts. Cell 1992, 70:139-151
18. Galaktionov K, Lee AK, Eckstein J, Draetta G, Meckler J, Loda M, Beach D: cdc25 phosphatases as potential oncogenes. Science 1995, 269:1575-1577
19. Noguchi T, Metz R, Chen L, Mattei MG, Carrasco D, Bravo R: Structure, mapping, and expression of erp, a growth factor-inducible gene encoding a nontransmembrane protein tyrosine phosphatase, and effect of erp on cell growth. Mol Cell Biol 1993, 13:5195-5205
20. Sun H, Tonks NK, Bar-Sagi D: Inhibition of Ras-induced DNA synthesis by expression of the phosphatase MKP-1. Science 1994, 266:285-288
21. Yao H, Labudda K, Rim C, Capodieci P, Loda M, Stork PJS: Cyclic adenosine monophosphate can convert epidermal growth factor into a differentiating factor in neuronal cells. J Biol Chem 1995, 270:1-6
22. Liu Y, Gorospe M, Yang C, Holbrook NJ: Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress: inhibition of c-jun N-terminal kinase activity and AP-1-dependent gene activation. J Biol Chem 1995, 270:8377-8380
23. Zinck R, Cahill MA, Kracht M, Sachsenmaier C, Hipskind RA, Nordheim A: Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1. Mol Cell Biol 1995, 15:4930-4938
24. Chu Y, Solski PA, Khosravi-Far R, Der CJ, Kelly K: The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 seven-maker mutation. J Biol Chem 1996, 271:6497-6501
25. Misra-Press A, Rim CS, Yao H, Roberson MS, Stork PJS: A novel MAP kinase phosphatase: structure, expression, and regulation. J Biol Chem 1995, 270: 14587-14596
26. Martell KJ, Kwak S, Hakes DJ, Dixon JE, Trent JM: Chromosomal localization of four human VH1-like protein-tyrosine phosphatases. Genomics 1994, 22: 462-464
27. Kwak SP, Dixon JE. Multiple dual specificity protein tyrosine phosphatases are expressed and regulated differentially in liver cell lines. J Biol Chem 1995, 270: 1156-1160
28. Muda M, Boschert U, Dickinson R, Martinou JC, Martinou I, Camps M, Schlegel W, Arkinstali S: MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase. J Biol Chem 1996, 271:4319-4326
29. Guan KL, Butch E: Isolation and characterization of a novel dual specific phosphatase, HVH2, which selectively dephosphorylates the mitogen activated protein kinase. J Biol Chem 1995, 270:7197-7203
30. Martell KJ, Seasholtz AF, Kwak SP, Clemens KK, Dixon JE: hVH-5: a protein tyrosine phosphatase abundant in brain that inactivates mitogen-activated protein kinase. J Neurochem 1995, 65:1823-1833
31. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire W: Human breast cancer: correlation of release and survival with amplification of the HER-2/neu oncogene. Science 1987, 235:177-182
32. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF: Studies of the HER-2neu proto-oncogene in human breast and ovarian cancer. Science 1989, 244: 707-712
33. Bos JL: Ras oncogenes in human cancer: a review. Cancer Res 1989, 49:4682-4689
34. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767
35. Tsutsumi Y, Naber SP, DeLellis RA, Wolfe HJ, Marks PJ, McKenzie SJ, Yin S: Neu oncogene protein and epidermal growth factor receptor are independently expressed in benign and malignant breast tissue. Hum Pathol 1990, 21:750-758
36. Mizukami Y, Nonomura A, Noguchi H, Tanija T, Kojasaki N, Saito Y, Hashimoto T, Matsubara F, Yanaihara Y: Immunohistochemical study of oncogene product ras p21, c-myc, and growth factor EGF in breast carcinomas. Anticancer Res 1991, 11:1485-1494
37. Lee AKC, Wiley B, Loda M, Bosari S, Dugan JM, Hamilton W, Heatley GJ, Cook L, Silverman ML: DNA ploidy, proliferation, and neu oncogene overexpression in breast carcinoma. Mod Pathol 1992, 5:61-67
38. Sidransky D, Messing E: Molecular genetics and biochemical mechanisms in bladder cancer: oncogenes, tumor suppressor genes, and growth factors. Urol Clin North Am 1992, 19:629-639
39. Yu M, Leav BA, Leav I, Merk FB, Wolfe HJ, Ho SM: Early alterations in ras proto-oncogene mRNA expression in testosterone and estradiol-17β induced prostatic dysplasia of noble rats. Lab Invest 1993, 68:33-44
40. c-src with two major signaling pathways in human breast cancer. Proc Natl Acad Sci USA 1994, 91:83-87
41. Loda M, Lipman J, Cukor B, Bur M, Kwan P, DeLellis R: Nodular foci in parathyroid adenomas and hyperplasia: an immunohistochemical analysis of proliferative activity. Hum Pathol 1994, 25:1050-1056
42. Potter M: Immunoglobulin-producing tumors and myeloma proteins of mice. Physiol Rev 1972, 52:613-719
43. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976, 72:248-254
44. Stork P, Loda M, Bosari S, Wiley B, Poppenhunsen K, Wolfe H: Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction. Oncogene 1991, 6:857-862
45. Warrington JA, Wasmuth JJ: Sublocalization of seven human simple sequence repeat polymorphic markers: D5S349, D5S351, and D5S355 to 5q11.2-q13.1, D5S350 to 5q13.1-p14, D5S352 to 5q31.2-q33.1, D5S353 to 5q33.2-qter, and D5S354 to 5q13.2-q15. Genomics 1993, 15:241-242
46. Muller U, Warman ML, Mulliken JB, Weber JL: Assignment of a gene locus involved in craniosynostosis to chromosome 5qter. Hum Mol Genet 1993, 2:119-122
47. Weber JL, Polymeropoulos MH, May PE, Kwitek AE, Xiao H, McPherson JD, Wasmuth JJ: Mapping of human chromosome 5 microsatellite DNA polymorphisms. Genomics 1991, 11:695-700
48. Hudson TJ, Engelstein M, Lee MK, Ho EC, Rubenfield MJ, Adams CP, Housman DE, Dracopoli NC: Isolation and chromosomal assignment of 100 highly informative human simple sequence repeat polymorphisms. Genomics 1992, 13:622-629
49. Louis DN, von Deimling A, Seizinger BR: A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens. Am J Pathol 1992, 141:777-782
50. Housman D: Human DNA polymorphism. N Eng J Med 1995, 332:318-320
51. Jessup J, Lavin PT, Andrews CJ, Loda M, Mercurio A, Minsky B, Mies C, Cukor B, Bleday R, Steele GJ: Sucrase-isomaltase is an independent prognostic marker for colorectal cancer. Dis Colon Rectum 1995, 38: 1257-1264
52. McNemar Q: Note on the sampling error of the difference between correlated proportions or percentages. Psychometrica 1947, 12:153-157
53. Fanning P, Bulovas K, Saini KS, Libertino JA, Joyce AD, Summerhayes IC: Elevated expression of pp60 c-src in low grade human bladder carcinoma. Cancer Res 1992, 52:1457-1462
54. Magi-Galluzzi C, Loda M: Molecular pathology of preinvasive neoplasia in the prostate gland. Eur Urol 1996 (in press)
55. Peehl DM: Oncogenes in prostate cancer: an update. Cancer 1993, 71:1159-1164
56. Kawamata H, Kameyama S, Oyasu R: In vitro and in vivo acceleration of the neoplastic phenotype of a low-tumorigenicity rat bladder carcinoma cell line by transfected transforming growth factor-α. Mol Carcinogen 1994, 9:210-219
57. Zhau HE, Zhang X, Eschenbach AC: Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer. Mol Carcinogen 1990, 3:254-257
58. Stein D, Wu J, Fuqua SAW, Roonprapunt C, Yajnik V, D'Eustachio P, Moskow JJ, Buchberg AM, Osborne CK, Margolis B: The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer. EMBO J 1994, 13:1331-1340
59. Thompson TC, Southgate J, Kitchener G, Land H: Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell 1989, 56:917-930
60. Kastrinakis WV, Ramchurren N, Rieger KM, Hess DT, Loda M, Steele G, Summerhayes IC: Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression. Oncogene 1995, 11:647-652
61. Charles CH, Abler AS, Lau LF: cDNA sequence of a growth factor-inducible immediate early gene and characterization of the encoded protein. Oncogene 1992, 7:187-190
62. Charles CH, Sun H, Lau LF, Tonks NK: The growth factor-inducible immediate early gene 3CH134 encodes a protein-tyrosine-phosphatase. Proc Natl Acad Sci USA 1993, 90:5292-5296
63. Seth A, Gonzalez FA, Gupta S, Raden DL, Davis RJ: Signal transduction within the nucleus by mitogen-activated protein kinase. J Biol Chem 1992, 267:24796-24804
64. Traverse S, Seedorf K, Paterson H, Marshall CJ, Cohen P, Ullrich A: EGF triggers neuronal differentiation of PC 12 cells that over-express the EGF receptor. Curr Biol 1994, 4:694-701
65. Traverse S, Gomez N, Paterson H, Marshall C, Cohen P: Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Biochem J 1992, 288:351-355
66. Wu J, Lau LF, Sturgill TW: Rapid deactivation of MAP kinase in PC12 cells occurs independently of induction of phosphatase MKP-1. FEBs Lett 1994, 353:9-12
67. Ward Y, Gupta S, Jensen P, Wartmann M, Davis RJ, Kelley K: Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1. Nature 1994, 367:651-654
68. Alessi DR, Gomez N, Moorhead G, Lewis T, Keyse SM, Cohen P: Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL 100, in various cell lines. Curr Biol 1995, 5:283-295
69. Hunter T: Protein kinases and phosphatases: the Yin and Yang of protein phosphorylation and signaling. Cell 1995, 80:225-236
70. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effect of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995, 270:1326-1331